Clinical Trial: Study of RMC-9805 in Participants With KRASG12D-Mutant Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-small Cell Lung Cancer (NSCLC)
Study Type: INTERVENTIONAL
Official Title: Phase 1/1b, Multicenter, Open-Label, Study of RMC 9805 in Participants With Advanced KRASG12D-Mutant Solid Tumors
Brief Summary:
This study is to evaluate the safety and tolerability of RMC-9805 in adults with KRAS G12D-mutant solid tumors.
Read more